Health
Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies – News-Medical.Net
Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs,…
With the resurgence of the COVID-19 pandemic looming large in many parts of the world, the need for immunological tools such as monoclonal antibodies (mAbs) is more urgent, whether for diagnosis, treatment, or research on the virus. Now, a recent study published on the preprint server bioRxiv* in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.
The RBD in SARS-CoV-2 Immunology
The focus of most antibody developmen…
-
Noosa News12 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General20 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
Business23 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Business17 hours agoCounter drone company surges past $1 billion valuation with new contract win